SEC Tracker
Get the app
AVR · XBRL financial data

Anteris Technologies Global financial statements, every quarter

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (AVR's year ends in late December)

In thousands of dollarsMar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers556618429310*4941,009
Cost of goods and services sold20714812391*114233
Research and development16,45616,34016,81019,514*17,45723,369
Selling, general and administrative5,6735,0145,7619,670*6,9308,404
Operating income (loss)(21,780)(20,884)(22,265)(28,965)*(24,007)(30,997)
Interest expense26221510*27131
Other income (expense)9114814781*1,7222,420
Income tax expense (benefit)0000*4920
Net income (loss)(21,864)(20,834)(22,244)(29,202)*(23,024)(29,094)
Earnings per share, basic USD per share(0.61)(0.58)(0.62)(0.74)*(0.28)(0.30)
Earnings per share, diluted USD per share(0.61)(0.58)(0.62)(0.74)*(0.28)(0.30)
Weighted average shares, basic thousands of shares36,01236,06236,06239,480*83,01097,340
Weighted average shares, diluted thousands of shares36,01236,06236,06239,480*83,01097,340

Balance sheet

CSV

Fiscal quarters (AVR's year ends in late December)

In thousands of dollarsMar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents48,95528,4389,1196,697283,210249,904
Accounts receivable18968723432231548
Inventory3644494361521228
Total current assets52,98232,21211,22415,676286,669260,651
Property and equipment, net4,6604,9335,2955,2615,1785,620
Right-of-use asset1,0082,1211,9711,9952,7702,630
Total assets58,79239,87819,07422,997294,722272,507
Accounts payable5,4795,3984,27611,0943,7905,099
Accrued liabilities5,7353,9104,2643,4254,8855,612
Total current liabilities14,42513,33913,43121,37313,69418,360
Lease liability, non-current5351,7101,6051,6782,4062,247
Total liabilities15,67915,84615,71523,25016,31120,837
Accumulated deficit(298,252)(319,086)(341,330)(370,532)(393,556)(422,650)
Total stockholders' equity43,25924,4063,698(93)278,445251,387
Total liabilities and equity58,79239,87819,07422,997294,722272,507
Common shares outstanding (cover page) thousands of shares36,06236,06241,19897,23297,34297,458

Cash flows

CSV

Fiscal quarters (AVR's year ends in late December)

In thousands of dollarsMar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(21,864)(20,834)(22,244)(29,202)*(23,024)(29,094)
Stock-based compensation1,7031,541*1,505*3,034*1,8162,116*
Depreciation and amortization403418*417*423*429469*
Net cash from operating activities(21,489)(19,535)*(18,252)*(18,527)*(28,680)(20,797)*
Purchases of property and equipment248537*772*397*137648*
Net cash from investing activities1,110(537)*(772)*(397)*(182)(648)*
Proceeds from issuing common stock6181*0*25,200*——
Proceeds from issuing equity———year only——
Net cash from financing activities(1,091)(442)*(294)*22,382*299,511(877)*
Net change in cash(21,503)(20,517)*(19,319)*3,457*270,634(22,316)*

Compare with peers

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Anteris Technologies Global249,9041,009(20,797)*97.5M12.0 quarters 10-QJun 30, 2026
Catheter Precision6431,019(2,861)*14.4M0.6 quarters 10-QJun 30, 2026
RenovoRx9,479909(2,867)*45.1M3.3 quarters 10-QJun 30, 2026
Adm Tronics Unlimited223not reported(33)67.6M6.8 quarters 10-QJun 30, 2026
QHSLab317847(7.8)*15.0M40.6 quarters 10-QJun 30, 2026
Tenon Medical1,6771,279(2,758)*667,0470.6 quarters 10-QJun 30, 2026
Lucid Diagnostics33,404not reported(11,297)*203.2M3.0 quarters 10-QJun 30, 2026
Encision721,528(127)*16.9M0.6 quarters 10-QSep 30, 2025
SeaStar Medical Holding6,959615(2,994)*4.4M2.3 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.